| Drug Name | Valdoxan (agomelatine) |
|---|---|
| المجموعة الدوائية |
Anti-depressant
|
| نوع وسيلة تقليل المخاطر |
دليل ارشادي للممارس الصحي
|
| Specialty (Theraputic area) |
Psychiatry
|
| المخاطر |
To improve awareness on the need for monitoring liver function during treatment and the contraindication od use with potent CYP 1A2 inhibitors |
| دليل ارشادي للمريض |
|